(Q30711936)

26 June 2017

1 reference

title

Orlistat for the treatment of obesity: rapid review and cost-effectiveness model (English)

1 reference

26 June 2017

0 references

Foxcroft DR

1

1 reference

26 June 2017

Milne R

series ordinal

2

1 reference

26 June 2017

publication date

1 October 2000

1 reference

26 June 2017

1 reference

26 June 2017

volume

1

1 reference

26 June 2017

issue

2

1 reference

26 June 2017

page(s)

121-126

1 reference

Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group

26 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2000.00011.X

Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2000.00011.X

Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2000.00011.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2000.00011.X

Prospective study of intentional weight loss and mortality in overweight white men aged 40-64 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2000.00011.X

Outcomes of pharmacological and surgical treatment for obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2000.00011.X

Pain in the obese: impact on health-related quality-of-life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2000.00011.X

Impairment of health and quality of life in people with large waist circumference.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2000.00011.X

Impairment of health and quality of life using new US federal guidelines for the identification of obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2000.00011.X

Cost-effectiveness league tables: More harm than good?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2000.00011.X

10.1046/J.1467-789X.2000.00011.X

21 January 2018

Identifiers

DOI

1 reference

release_toq2pame5rdppfo5uxxalyyj6m

26 June 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/toq2pame5rdppfo5uxxalyyj6m

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference